Geography once drove disparity, but access now hinges on how effectively centers can employ modern donor-utilization tools.

Jonathan Cunningham discusses how AI might help, from patient selection to event adjudication.

Both CV mortality and major bleeding were rarer when antiplatelets weren’t added, with no tradeoff in ischemic events.

The study of LAAO cases provides physicians with evidence they can cite when requesting tools for additional protection.

Final follow-up from the trial shows durable protection against TLF, especially in chronic total occlusions and diffuse long ...

For primary prevention patients at high risk, such as those with a 10-year risk > 10%, the LDL target is less than 70 mg/dL (class 2a recommendation). For this group, treatment begins with a ...

The study emphasizes the importance of vigilance with diet and exercise, among other things, to reduce CV risk in type 2 diabetes.

Operative mortality fell over time, but there was a concerning uptick in recent years attributed to low-volume sites.

In hypothetical situations, physicians chose intensive treatment more often if BP and mobility metrics were available.

The vast majority of patients presenting with type 1 NSTEMI undergo invasive coronary angiography in the US, with most receiving PCI, according to an analysis presented this week at CRT 2026. But as ...

Patients already had high NT-proBNP levels at baseline, though, raising questions about the quality of GDMT, Nancy Sweitzer ...

There was a consensus that more data are needed to answer this question, with discussions about what such a trial would look like.